Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00636337 · ClinicalTrials.gov registry record · NA

Inattention in Childhood Cancer Survivors

A NA study of Childhood Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT00636337 is a NA study of Childhood Cancer that has completed, run by Duke University. The registered enrollment target is 23 participants, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00636337, a NA study of Childhood Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lymphoblastic leukemia, brain tumors). Specific Aim 2: To estimate the effect size of this cognitive training program on measures of attention and working memory in survivors of childhood cancer in order to determine whether a larger-scale clinical trial is warranted.

Conditions Studied

Interventions

  • BEHAVIORAL Placebo
  • BEHAVIORAL Attention Training

Study Locations (1)

North Carolina

  • Duke University Medical Center Preston Robert Tisch Brain Tumor Center - Durham

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2007-12
Est. Completion 2012-11
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT00636337

The ClinicalTrials.gov registry entry for NCT00636337 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,471-participant average among 23 other Childhood Cancer trials with a reported enrollment target (98% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00636337 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00636337 about?

NCT00636337 is a clinical study titled "Inattention in Childhood Cancer Survivors". Specific Aim 1: To assess the feasibility and acceptability of a home-based, computerized cognitive training program with survivors of central nervous system-impacting pediatric cancer (e.g. acute lymphoblastic leukemia, brain tumors). Specific Aim 2: To estimate the effect size of this cognitive t...

What is the current status of trial NCT00636337?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2007-12. Estimated completion is 2012-11.

What conditions does trial NCT00636337 study?

This clinical trial studies the following conditions: Childhood Cancer.

What interventions are being tested in trial NCT00636337?

The interventions under investigation include: Placebo (BEHAVIORAL), Attention Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00636337?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00636337 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.